Which interventions appear most often on Adult Acute Myeloblastic Leukemia With Maturation (M2) trial records?

cytarabine is the most-linked intervention name on Adult Acute Myeloblastic Leukemia With Maturation (M2) records (6 trial links), followed by mitoxantrone hydrochloride. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Adult Acute Myeloblastic Leukemia With Maturation (M2)?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Adult Acute Myeloblastic Leukemia With Maturation (M2): early-phase trial registry

Q: How many clinical trials are there for Adult Acute Myeloblastic Leukemia With Maturation (M2)?

PlainTrial tracks 9 US clinical trials for Adult Acute Myeloblastic Leukemia With Maturation (M2), of which 0 are currently recruiting.

Compiled by PlainTrial · August 8, 2026

A small indexed set (9 trials) with no open enrollment listed right now.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

9 US clinical trials · none currently recruiting · #1,916 of 28,707 conditions by registered trial count

Adult Acute Myeloblastic Leukemia With Maturation (M2): 9 US clinical trials tracked, none currently recruiting.

Adult Acute Myeloblastic Leukemia With Maturation (M2) is the subject of 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 7 of these trials.

Enrollment posture brief

Registry condition adult-acute-myeloblastic-leukemia-with-maturation-m2

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Open-enrollment share among volume-matched conditions near Adult Acute Myeloblastic Leukemia With Maturation (M2)

Adult Acute Myeloblastic Leukemia With Maturation (M2) has no open enrollment in this registry pull (9 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Acute Myeloblastic Leukemia With Maturation (M2) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Adult Acute Myeloblastic Leukemia With Maturation (M2) is recruiting below its size-band peers.

0 of 9 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
One sponsor concentrates Adult Acute Myeloblastic Leukemia With Maturation (M2) research.

National Cancer Institute (NCI) accounts for 7 of 9 trials (77.8%). 3 distinct sponsors appear on at least one study for this condition label.
Most Adult Acute Myeloblastic Leukemia With Maturation (M2) trials plan to enrol fewer than 100 people.

Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.
Adult Acute Myeloblastic Leukemia With Maturation (M2) research is mostly interventional.

9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.